Brunei vs Panama: Death rate from cancer
Brunei
84.28 deaths per 100,000 people
in 2021
Panama
80.66 deaths per 100,000 people
in 2021
Brunei rank
106th
Panama rank
108th
Death rate from cancer over time
- Brunei
- Panama
How they compare
Brunei currently reports 84.28 deaths per 100,000 people against 80.66 deaths per 100,000 people in Panama, a difference of 3.62 deaths per 100,000 people.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Panama ahead.
Brunei ranks 106th and Panama ranks 108th of 194 countries.
Across the 3 decades both report, Brunei averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Brunei | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 57.3 deaths per 100,000 people | 71.57 deaths per 100,000 people | 14.26 deaths per 100,000 people | Panama |
| 2010s | 75.31 deaths per 100,000 people | 78.59 deaths per 100,000 people | 3.27 deaths per 100,000 people | Panama |
| 2020s | 84.24 deaths per 100,000 people | 78.34 deaths per 100,000 people | 5.9 deaths per 100,000 people | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Brunei or Panama?
- Brunei, at 84.28 deaths per 100,000 people against 80.66 deaths per 100,000 people in Panama as of 2021.
- What is the difference in death rate from cancer between Brunei and Panama?
- 3.62 deaths per 100,000 people, with Brunei ahead.
- How many years of comparable data are there for Brunei and Panama?
- 22 years are reported by both, from 2000 to 2021.
- How do Brunei and Panama rank globally for death rate from cancer?
- Brunei ranks 106th and Panama ranks 108th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.